Búsqueda en vivo
TopFind está obteniendo las coincidencias más recientes para tu búsqueda.
Revisamos 10000 resultados en vivo para cosentyx direct to patient platform y los redujimos a 3 opciones que parecen valer más la pena comparar primero.
Los temas más fuertes en esta lista son Patient Support y Pharmaceutical Access.
Fuente: Novartis Pharmaceuticals Corporation
Descripción
A manufacturer-backed access program in the US that allows cash-paying patients to bypass traditional insurance hurdles to obtain secukinumab directly. This ensures continuous access for those without standard coverage.
Ideal para
Cash Paying patients, Uninsured individuals, US residents y Manufacturer direct access
Valoración
Fuente: ASPN Pharmacies
Descripción
Specialized fulfillment and pharmacy services for secukinumab orders originating from the manufacturer's direct-access platform. They handle the cold-chain logistics and delivery of biologic pens and syringes to US patient addresses.
Ideal para
Direct To Patient delivery, Specialized pharmacy fulfillment, US biologic patients y Cold Chain pharmacy service
Valoración
Fuente: Novartis Malaysia
Descripción
Cosentyx (Secukinumab) is an interleukin inhibitor prescribed for plaque psoriasis and psoriatic arthritis. It is supplied as a 150 mg/mL solution for injection in a pre-filled pen or syringe.
Ideal para
Plaque psoriasis, Psoriatic arthritis y Interleukin inhibition
Valoración
| Comparar | Cosentyx Direct-to-Patient Platform | Cosentyx Direct Fulfillment Service | Cosentyx |
|---|---|---|---|
| Fuente | Novartis Pharmaceuticals Corporation | ASPN Pharmacies | Novartis Malaysia |
| Descripción | A manufacturer-backed access program in the US that allows cash-paying patients to bypass traditional insurance hurdles to obtain secukinumab directly. This ensures continuous access for those without standard coverage. | Specialized fulfillment and pharmacy services for secukinumab orders originating from the manufacturer's direct-access platform. They handle the cold-chain logistics and delivery of biologic pens and syringes to US patient addresses. | Cosentyx (Secukinumab) is an interleukin inhibitor prescribed for plaque psoriasis and psoriatic arthritis. It is supplied as a 150 mg/mL solution for injection in a pre-filled pen or syringe. |
| Ideal para | Cash Paying patients, Uninsured individuals, US residents y Manufacturer direct access | Direct To Patient delivery, Specialized pharmacy fulfillment, US biologic patients y Cold Chain pharmacy service | Plaque psoriasis, Psoriatic arthritis y Interleukin inhibition |
| Acción | |||
| Valoración |
Si quieres empezar con la opción más equilibrada, te recomiendo:
"Cosentyx Direct-to-Patient Platform de Novartis Pharmaceuticals Corporation."
Lo elegí porque The most effective path for US-based patients without insurance to access manufacturer-direct pricing and support.